Kabra Drugs Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

4.39

4.39

4.39

4.39

4.39

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

-5.12

-4.78

-4.60

-4.42

-4.36

Loan funds

Secured loans

1.38

1.03

0.90

0.65

0.67

Unsecured loans

-

-

-

-

-

Total

0.65

0.63

0.69

0.62

0.70

Uses of funds

Fixed assets

Gross block

-

-

0.17

0.17

0.17

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

-

-

0.16

0.13

0.09

Net block

-

-

0.01

0.04

0.08

Capital work-in-progress

-

-

-

-

-

Investments

-

-

-

-

-

Net current assets

Current assets, loans & advances

0.70

0.73

1.39

1.37

1.40

Less : current liabilities & provisions

0.05

0.10

0.71

0.79

0.78

Total net current assets

0.65

0.63

0.68

0.58

0.62

Miscellaneous expenses not written

-

-

-

-

-

Total

0.65

0.63

0.69

0.62

0.70

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

0.48

-

0.48

Number of equity sharesoutstanding (Lacs)

43.89

43.89

43.89

43.89

43.89